Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Fatigue
Description
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. MeSH
Hierarchy View
Subtype Terms (2)
Mental Fatigue
9 drugs (2 approved, 7 experimental)
Approved Indicated Drugs (7)
Phase 4 Indicated Drugs (27)
Phase 3 Indicated Drugs (22)
Phase 2 Indicated Drugs (35)
Other Experimental Indicated Drugs (47)
Organization Involved with Phase 4 Indications (84)
Federal University of Juiz de Fora
Hoosier Cancer Research Network
Los Angeles Biomedical Research Institute
National Cancer Institute (NCI)
National Institute of Mental Health (NIMH)
National Multiple Sclerosis Society
Rochester Center for Behavioral Medicine
State University of New York, Syracuse
Universidad Autonoma de Barcelona
Organization Involved with Phase 3 Indications (88)
Aase and Ejnar Danielsens Foundation
Australia and New Zealand Breast Cancer Trials Group
Cancer and Leukemia Group B (CALGB)
Department of Health and Human Services
Eastern Cooperative Oncology Group
Icahn School of Medicine at Mount Sinai
Instituto Mexicano del Seguro Social
International Breast Cancer Study Group
Medice Arzneimittel Pütter GmbH & Co KG
Mexican Institute of Social Security. Guadalajara
National Cheng Kung University
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
Norwegian University of Science and Technology
Organization Involved with Phase 2 Indications (84)
ABC Foundation School of Medicine
Canadian Institutes of Health Research (CIHR)
Center for Health, Exercise and Sport Sciences, Serbia
Chinese Academy of Medical Sciences
Clinical Research Support Center Kyush
Consortium of Multiple Sclerosis Centers
Health Sciences Centre Foundation, Manitoba
Istituto Clinico Humanitas - Rozzano (MI), Italy
Manitoba Medical Service Foundation
Midwestern Regional Medical Center
Minnesota Oncology Hematology, P.A.
National Center for Complementary and Integrative Health (NCCIH)
National Institute for Health Research, United Kingdom
National Institute of Allergy and Infectious Diseases (NIAID)
National University of Singapore
Northwest Cancer Specialists, P.C.
Oregon Health and Science University
Research Foundation for Mental Hygiene, Inc.
Saiseikai Fukuoka General Hospital
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (61)
Associazione Umbra per la lotta Contro il Cancro
Bangabandhu Sheikh Mujib Medical University
Case Western Reserve University
China Academy of Chinese Medical Sciences
European Parkinson Therapy Centre
Faculty of Sport and Physical Education, Novi Sad
Federal University of Health Science of Porto Alegre
National Taiwan Sport University
Network Italiano Cure di Supporto in Oncologia
Shandong University of Traditional Chinese Medicine
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
